Epigenetic factors influencing resistance to nuclear reprogramming

Slides:



Advertisements
Similar presentations
Transcriptional-level control (10) Researchers use the following techniques to find DNA sequences involved in regulation: – Deletion mapping – DNA footprinting.
Advertisements

Methylation, Acetylation and Epigenetics
EPIGENETICS AND CANCER JILLIAN FROELICK, GRACE LEMPP, NIKHIL UMESH, PAIGE TUMMONS.
1 Lecture 2: Nuclear Reprogramming. Nuclear Reprogramming 2 Switch of gene expression from one cell type to another Switch from a differentiated, specialized.
STEM CELLS Image Credit: Mesenchymal precursor cellsMesenchymal precursor cells.
The Genetic Basis of Development
Regulation of Gene Expression
Regulation of Gene Expression. You Must Know The functions of the three parts of an operon. The role of repressor genes in operons. The impact of DNA.
Eukaryotic Gene Expression Managing the Complexities of Controlling Eukaryotic Genes.
The importance of telomerase in maintaining chromosome integrity.
Histone Methylation Marks : Permanent or Reversible?
Outline Molecular Cell Biology Assessment Review from last lecture Role of nucleoporins in transcription Activators and Repressors Epigenetic mechanisms.
Molecules and mechanisms of epigenetics. Adult stem cells know their fate! For example: myoblasts can form muscle cells only. Hematopoetic cells only.
Nuclear Reprogramming in Cells by J. B. Gurdon, and D. A. Melton Science Volume 322(5909): December 19, 2008 Published by AAAS.
Chapter 2. Differential gene expression in Development
Gene Expression.
Chromatin Regulation September 20, 2017.
Development, Stem Cells, and Cancer
Chromatin Control of Developmental Dynamics and Plasticity
Xiu-Zhen Zhang  Reproductive BioMedicine Online 
Transcriptional Memory: Staying in the Loop
Regulation of Protein Synthesis
Ch. 15 Warm-Up Compare DNA methylation and histone acetylation.
Coordinately Controlled Genes in Eukaryotes
Using Epigenetic Reprogramming to Treat Pediatric Brain Cancer
An Epigenetic Perspective on Developmental Regulation of Seed Genes
Beyond genetics: epigenetic code in chronic kidney disease
Human Somatic Cell Nuclear Transfer Is Alive and Well
The Curious Case of Bivalent Marks
Jacob H. Hanna, Krishanu Saha, Rudolf Jaenisch  Cell 
A twin approach to unraveling epigenetics
Epigenetics of the male gamete
The Epigenomics of Cancer
Rudolf Jaenisch, Richard Young  Cell 
Control of the Embryonic Stem Cell State
Silencing Insulin Resistance through SIRT1
S. Tamir Rashid, Graeme J.M. Alexander  Journal of Hepatology 
Genome-Wide Epigenetics
Molecular Roadblocks for Cellular Reprogramming
Epigenetic effects on the embryo as a result of periconceptional environment and assisted reproduction technology  Emma Lucas  Reproductive BioMedicine.
Proteins Kinases: Chromatin-Associated Enzymes?
Elanor N. Wainwright, Paola Scaffidi  Trends in Cancer 
Objective 8: TSWBAT describe the discovery of stem cells and their applications in medical research and regenerative medicine.
Figure 2 Histone acetylation regulates gene expression
Basic concepts of epigenetics
Crosstalk among Histone Modifications
Environmental epigenetics of asthma: An update
“Transflammation”: When Innate Immunity Meets Induced Pluripotency
Long Noncoding RNAs in Cell-Fate Programming and Reprogramming
Functional and Mechanistic Diversity of Distal Transcription Enhancers
A Transcriptional Logic for Nuclear Reprogramming
Ananda Kishore Mukherjee, Shalu Sharma, Shantanu Chowdhury 
Epigenetic Transitions in Germ Cell Development and Meiosis
Epigenetics of Reprogramming to Induced Pluripotency
Volume 65, Issue 5, Pages e8 (March 2017)
Eukaryotic Gene Regulation
Torsten Klengel, Elisabeth B. Binder  Neuron 
Embryonic and adult stem cell therapy
A Role for Epigenetics in Psoriasis: Methylated Cytosine–Guanine Sites Differentiate Lesional from Nonlesional Skin and from Normal Skin  Johann E. Gudjonsson,
Genetic and Epigenetic Regulators of Pluripotency
Chromatin Repressive Complexes in Stem Cells, Development, and Cancer
Transcriptional and Developmental Functions of the H3
NuRD and Pluripotency: A Complex Balancing Act
Hariharan Easwaran, Hsing-Chen Tsai, Stephen B. Baylin  Molecular Cell 
The Aging Epigenome Molecular Cell
Volume 55, Issue 4, Pages (August 2014)
Torsten Klengel, Elisabeth B. Binder  Neuron 
Histone deacetylase inhibitors in cancer therapy
CRISPR Craze to Transform Cardiac Biology
Kevin Huang, Guoping Fan  Cell Stem Cell 
Presentation transcript:

Epigenetic factors influencing resistance to nuclear reprogramming Vincent Pasque, Jerome Jullien, Kei Miyamoto, Richard P. Halley-Stott, J.B. Gurdon  Trends in Genetics  Volume 27, Issue 12, Pages 516-525 (December 2011) DOI: 10.1016/j.tig.2011.08.002 Copyright © 2011 The Authors Terms and Conditions

Figure 1 Different strategies induce nuclear reprogramming towards pluripotency. (a) During reprogramming by nuclear transfer to eggs, the nucleus of a cell is transplanted into an unfertilised egg whose own nucleus has been removed [1]. The resulting embryos, larvae and adults have the same genetic constitution as the donor nucleus. The animal and vegetal poles of the egg are shown in brown and yellow, respectively. (b) For nuclear reprogramming by nuclear transfer to Xenopus oocytes, multiple mammalian nuclei are transplanted into the nucleus (germinal vesicle) of a meiotic prophase I oocyte [5]. Transcriptional reactivation of previously silenced genes is induced without cell division or DNA synthesis, and no new cell types are formed. The animal and vegetal poles of the oocyte are shown in brown and yellow, respectively. (c) The nuclei of distinct cell types can be induced to reside within a common cytoplasm [8]. The fused cells form heterokaryons, in which the nuclei remain as separate entities, and these can be maintained by inhibiting cell division. (d) Pluripotency can be induced in cultured somatic cells by overexpression of embryonic stem (ES) cell-specific transcription factors or by overexpression of small noncoding RNAs together with histone deacetylases inhibitors [11,58]. The cells obtained are very similar to ES cells. Adapted, with permission, from [14]. Trends in Genetics 2011 27, 516-525DOI: (10.1016/j.tig.2011.08.002) Copyright © 2011 The Authors Terms and Conditions

Figure 2 Resistance to reprogramming increases as cells differentiate. The extent of resistance to reprogramming (equivalent to a decrease in reprogramming efficiency) as cells differentiate, when tested by nuclear transfer (a–c), cell fusion (heterokaryon) (d) and induced pluripotency (e). Reproduced, with permission, from [15] (a), [16] (b), [5] (c), [19] (d) (but also see [100,101]) and [22] (e). Abbreviations: ES, embryonic stem; ESRA, retinoic-acid differentiated embryonic stem cells. Trends in Genetics 2011 27, 516-525DOI: (10.1016/j.tig.2011.08.002) Copyright © 2011 The Authors Terms and Conditions

Figure 3 Hypothetical model of chromatin state changes at gene regulatory regions during reprogramming and differentiation. Epigenetic reprogramming of chromatin states requires several events, some of which are summarised here. A fully repressed gene (a) must be remodelled to evict repressive nucleosomes, which may contain histone variants such as macroH2A and multiple repressive histone modifications. Once accessible, regulatory regions may be bound by transcriptional regulators with the ability to recruit activities, such as H3K4 methyltransferases. Loss of repressive histone modifications, such as H3K9me2/3, H3K27me2/3 and DNA methylation and demethylation may occur actively or passively through cell divisions. Histone acetylation also strongly increases transcriptional activity (b). The opposite route may lead to transcriptional silencing of differentiation genes during reprogramming towards pluripotency, or silencing of pluripotency genes during cell differentiation. The steps represented may occur simultaneously and/or in a different order according to the gene and system considered. The order of the epigenetic events that occur during nuclear reprogramming may not be in the exact reverse order of the events that occur during cell differentiation. Trends in Genetics 2011 27, 516-525DOI: (10.1016/j.tig.2011.08.002) Copyright © 2011 The Authors Terms and Conditions